Trial intelligence / Profile preview

Plaquenil in Euthyroid Hashimoto's Thyroiditis

NCT02126683Unknown

Sponsor
National Taiwan University Hospital
Start
Apr 2014
Primary completion
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of hydroxychloroquine in Hashimoto's thyroiditis (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Change of thyroid auto-antibodies at 18 months. Status: unknown.

02

Drugs

hydroxychloroquine
03

Conditions

Hashimoto's thyroiditis

Beyond the preview

Go deeper on NCT02126683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02126683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call